Facial Injection Danger Zones: Vessels & Nerves to Avoid

Every Needle Passes Through a Complex Anatomical Maze

If you are dealing with a filler complication — or trying to understand why one occurred — it helps to know what lies beneath the surface where your filler was placed. You may have been told the injection was routine, but beneath every injection site lies an extraordinarily complex three-dimensional anatomical structure: arteries coursing through multiple layers, veins forming dense networks, and nerve branches distributed like wiring throughout every tissue plane.

With each injection, the needle tip navigates blindly through this structure — unless you can "see" everything beneath the skin.

Key Insight: At FILLER REVISION, our clinical experience confirms that facial vascular anatomy shows significant individual variation. The "standard anatomy" in textbooks represents only statistical averages — your blood vessels may course in entirely different positions. This is why even experienced injectors can encounter unexpected complications, and why we check with ultrasound before revision.

The Basic Architecture of the Facial Vascular System

Major Arterial Sources

The facial blood supply comes primarily from two arterial systems:

External carotid artery system:

• Facial artery: Ascends along the mandibular border, passing the oral commissure and nasal ala, reaching the medial canthus (in most people continuing as the angular artery)
• Superior and inferior labial arteries: Branch from the facial artery, forming circular anastomoses in the lips
• Superficial temporal artery: Supplies the temple and lateral forehead

Internal carotid artery system:

• Ophthalmic artery: Forms extensive anastomotic networks with facial vessels through intraorbital branches
• Supratrochlear and supraorbital arteries: Supply the central and upper forehead

The Dangerous Anastomotic Network

The most critical anatomical fact: extensive anastomoses exist between the external and internal carotid artery systems. A dye study in six cadavers demonstrated the route: dye injected into the superficial temporal artery reached the eye on the same side in 3 of 12 globes, and dye injected into the facial artery in 5 of 12 (Tansatit et al., 2015). This means filler that accidentally enters a facial artery may travel retrograde through these networks to reach the ophthalmic artery, causing vascular occlusion or even blindness.

Where Have Filler-Related Vision-Loss Cases Actually Occurred?

Published cases of blindness after filler cluster in the center and upper part of the face: the nose, forehead and glabella. A 2025 report by the American Academy of Ophthalmology (AAO) reviewed 19 studies describing 198 cases of vision loss from filler entering a blood vessel. Of the 226 injection sites recorded (some patients were injected in more than one place), 90 were the nose (40%), 56 the forehead (25%), 26 the glabella (12%), 21 the temple (9%), 17 a site the report lists separately as "frontal" (7%) and 9 the nasolabial fold (4%), with one case each from the lip, eyebrow, cheek and upper eyelid; the nose, forehead, glabella and frontal sites together made up 189 (84%) (Foster et al., 2025). A separate review of 365 cases published between 2018 and 2023, which may overlap with the AAO set, found the same top three: nose (40.6%), forehead (27.7%) and glabella (19.0%) (Doyon et al., 2024). An earlier 2015 review of 98 cases ranked the glabella first (38.8%), then the nose (25.5%), nasolabial fold (13.3%) and forehead (12.2%); nearly half of those cases involved autologous fat (Beleznay et al., 2015), whereas hyaluronic acid accounted for 79.6% to 83% in the two later reviews.

These percentages count published case reports. They are not incidence rates: how often each area is injected, which material is used and which cases get written up all shape the ranking, so the numbers cannot be used to compare the risk of a single injection in one area against another. Beleznay and Doyon both describe blindness as a rare complication, but the outcome is poor when it happens: vision was unchanged in 70% of patients in the AAO report, and 68.2% had no recovery in the Doyon review.

Facial Arteries One by One: Course and Depth

Textbook diagrams show average positions. Each artery below comes with a depth or variation rate that researchers actually measured, which shows why the same area can carry different risk from one person to the next.

Where are the facial and angular arteries, and how deep do they run?

The facial artery climbs from the jawline to the side of the nostril and becomes shallower as it nears the inner corner of the eye. A meta-analysis of 12 studies measured its average depth at five levels: about 9.7 mm at the mouth corner, about 10.3 mm between the mouth corner and the nostril (with wide variation between studies, 95% CI 5.2–15.4 mm), about 9.2 mm at the nostril, about 4.7 mm between the nostril and the inner eye corner, and about 2.4 mm at the inner eye corner (Trzeciak 2025, PMID 40164893). In a Doppler study of 66 half-faces in 33 people, the facial artery ended as the angular artery in 59.1%, and the authors concluded that around the nasolabial fold it runs in the dermis and subcutaneous tissue; its diameter narrowed from about 1.56 mm at the jaw to about 1.32 mm at the nostril (Shen 2023, PMID 37327736).

Is the dorsal nasal artery the same in everyone?

No. In an anatomical study of 50 noses, 34% had a dorsal nasal artery on both sides, 28% had a single larger one, and the remaining 38% had only a fine subcutaneous network (Tansatit 2017, PMID 28032167; see "The Nose" section below). An ultrasound study of 60 people found the nasal arteries ran in the superficial layer in about 91.7% at the nasal root, 80% at the mid-dorsum and 98.3% at the tip (Alfertshofer 2022, PMID 34363459).

How deep are the supratrochlear and supraorbital arteries in the forehead?

The supratrochlear artery gets shallower as it rises, while the supraorbital artery stays at a fairly constant depth. A meta-analysis of 5 studies measured the supratrochlear artery at about 4.45 mm at glabellar level and 3.53 mm above the brow, and the supraorbital artery at about 5.68 mm and 5.53 mm at the same two levels (Trzeciak 2025, PMID 39764659). A Doppler study of 71 people found the supratrochlear artery 1.8–5.9 mm below the skin and 0.7–3.7 mm from the periosteum (the bone lining) at brow level, sitting deeper below the skin with higher BMI and older age (Güvenç 2022, PMID 36066329).

Where do the transverse facial artery perforators come out?

In a study of 48 half-faces from 24 cadavers, transverse facial artery perforators were found in 96%, usually as a single dominant perforator (91.3%). It emerged on average about 31.7 mm outward and 40.3 mm downward from the outer eye corner, at a depth of about 11.3 mm; after passing through the SMAS (the superficial muscle-and-fascia layer), it branched into a subdermal network about 3–5 mm deep, spread below and outside the eye socket and over the cheekbone (Lee 2026, PMID 41968573).

What these numbers mean for you

At the same brow level, the supratrochlear artery sat anywhere from 1.8 to 5.9 mm below the skin; one person has a single large dorsal nasal artery, another only a fine network. Even along one facial artery, the average depth changes from about 10 mm near the nasolabial fold to about 2 mm at the inner eye corner. That is why the vessels to check before injection are your own, and textbook averages are only a reference point.

Detailed Analysis of High-Risk Zones

The Nose: The Most Common Site in Published Blindness Cases

Nasal filler is a common non-surgical rhinoplasty method. In published blindness cases, the nose is also the most frequent injection site, at roughly 40% in both the AAO 2025 report and the Doyon 2024 review.

Anatomical risk factors:

• The dorsal nasal artery is a terminal branch of the ophthalmic artery that anastomoses with the angular artery of the facial artery, but its pattern varies: in a dissection of 50 cadaver noses, 34% had arteries on both sides, 28% had a single larger artery (up to about 1.2 mm), and in 38% the vessels were small and spread as a network under the skin (Tansatit 2017, PMID 28032167). The authors advise particular care with this artery when injecting the upper and middle nasal dorsum
• Dense lateral nasal artery branches around the nasal ala
• Thin nasal skin with minimal subcutaneous tissue allows fillers to easily compress vessels
• Individual vascular variation is particularly prominent in the nose

Nasal filler displacement and complications are common clinical problems. Learn more about nose filler displacement.

The Glabella: A Highway to the Eyes

The supratrochlear and supraorbital arteries in the glabellar region connect directly to the ophthalmic artery. Filler entering these vessels can travel retrograde extremely rapidly to the central retinal artery, causing irreversible blindness. A review of the world literature on avoiding and treating filler-induced blindness has underscored the critical importance of this anatomical knowledge (Beleznay et al., 2015).

The Temple: Hidden Risk Zone

Temple filler improves hollowing, but the superficial temporal artery and deep temporal arteries form complex vascular networks in this area. Deep injection may affect vascular branches leading to the meninges.

The temple carries a risk of blindness as well as skin necrosis: 21 of the 226 injection sites in the AAO 2025 report (9%) were in the temple, and in the cadaver dye study above, dye from the superficial temporal artery reached the eye. For headache or pressure after temple filler, see headache after temple filler.

The Mechanism of Vascular Occlusion

From Injection to Onset

When filler accidentally enters an artery or compresses an external vessel:

1. Mechanical obstruction: Filler material physically blocks blood flow
2. Vasospasm: Vessel walls contract violently when stimulated, further reducing blood flow
3. Retrograde embolization: Under injection pressure, filler may travel against blood flow direction to reach distant branches
4. Secondary thrombosis: After blood flow stasis, clotting factors activate, forming thrombi that expand the blockage area

Key Insight: Vascular occlusion is a medical emergency. From the moment skin blanching, a color change, or any eye symptom appears (it is not always painful), there is no safe time to wait: the earlier it is treated, the better. Learn more about how vascular occlusion happens and what to do.

Is a deeper layer always safer?

Not necessarily. The studies point to a different lower-risk layer in each area, and none of them is safe everywhere on the face.

• Glabella: in a Doppler study of 71 people, the supratrochlear artery lay 1.8–5.9 mm below the skin at brow level. The authors concluded that intradermal injection just beneath the frown line may be possible, while subcutaneous and supraperiosteal injections there appear risky (Güvenç 2022, PMID 36066329).
• Nose: where a single large dorsal nasal artery is present, it runs in the subcutaneous layer along the midline of the upper and middle nose, above the preperiosteal plane (Tansatit 2017, PMID 28032167).
• Temple: even in the supraperiosteal plane that guidelines favor, angiograms identified four possible routes from the deep temporal arteries to the ophthalmic artery (in patients with carotid stenosis or vascular malformations, where collateral vessels show up more clearly). The authors note the chance of filler traveling these routes may be low, but it is not impossible (Sheth 2025, PMID 39749811).
• Around the nasolabial fold: the authors concluded that the facial artery runs in the dermis and subcutaneous tissue here. The authors suppose that a deep injection onto the periosteum may be safer than one in the SMAS layer; this is a hypothesis, not a tested result (Shen 2023, PMID 37327736).
• Depth alone does not keep filler in place: in 30 cadaver faces injected on the periosteum, most of the hyaluronic acid flowed back into the loose areolar layer above it, and vessels ran at several levels with anastomoses, especially in the glabella, nasal dorsum, and temple (Zhang 2023, PMID 37717300).

So "deep" is not a guarantee. What matters is where the vessels actually run in that area of your face.

Why Anatomy Knowledge Matters for Revision Patients

For patients presenting at FILLER REVISION with complications, understanding facial anatomy explains not only what went wrong but also why safe revision requires the same anatomical precision — if not more. Correcting displaced or problematic filler means working in tissue that has already been altered by previous injections, inflammation, or scarring. The vascular and nerve structures are still there, and in some cases, their positions may have shifted due to the filler itself. This is why every revision procedure at FILLER REVISION begins with ultrasound mapping of both the filler deposits and the surrounding vascular anatomy. Navigating these danger zones safely during revision is just as important as avoiding them during the original injection.

Nerve Distribution and Injection Risks

Beyond vascular risks, facial nerve distribution must also be well understood:

Three Branches of the Trigeminal Nerve

• Ophthalmic nerve (V1): Supplies sensation to forehead and upper eyelid
• Maxillary nerve (V2): Supplies sensation to mid-face (cheek, nasal ala, upper lip)
• Mandibular nerve (V3): Supplies sensation to lower face and motor function to masticatory muscles

Facial Nerve Branches

The facial nerve controls facial expression muscles. Facial nerve paralysis after filler is rarely reported, and the case series found so far all involve injections behind the ear (used to change the ear's angle): in 15 patients with complete one-sided facial paralysis after retroauricular hyaluronic acid injection that had not improved after two weeks of conservative treatment, MRI showed the filler spreading well beyond the injection site, with swelling and enhancement of the facial nerve (Qu 2026, PMID 41807623); in another 4 cases, angiography showed a vascular embolism (Zheng 2025, PMID 39160403). The mechanism is not yet settled.

What to Do About Nerve Symptoms After an Injection

New one-sided facial weakness, inability to close the eye, or a drooping mouth after an injection should be treated like blurred vision, double vision, or slurred speech: go straight to the emergency department, contact the injecting clinic on the way, and do not wait for a call back. Only persistent numbness at the injected area with no other symptoms calls for a prompt follow-up visit instead. Published cases are too few to estimate recovery time; in one series, facial movement improved after the vascular blockage was treated (Zheng 2025).

Real case → 36-hour delayed vascular rescue via ultrasound-guided IAHA — nasolabial fold vascular occlusion rescued even after a 36-hour delay, using ultrasound mapping of facial artery branches. This is not a grace period: symptoms still need immediate treatment.

What Ultrasound (Ultrasonography) Can Show During Injection and Revision

"Seeing" Beneath the Skin

High-resolution ultrasound provides real-time anatomical information before, during, and after injection:

Pre-injection assessment: Personalized vascular mapping, identification of variant arteries, confirmation of prior filler residue locations, and tissue layer evaluation.

Intra-procedural guidance: Real-time needle tip confirmation, avoidance of identified vessels, monitoring of filler spread direction, and watching for changes in blood flow and filler distribution.

Post-injection monitoring: Confirmation of final filler distribution, assessment for signs of vascular compression, and baseline data for future adjustments.

What the evidence shows so far: ultrasound lets the doctor see where your vessels actually run and where old filler sits, for example whether your dorsal nasal arteries run on both sides, as a single larger artery, or only as a fine network (34% / 28% / 38% in the dissections above), or whether your facial artery ends as the angular branch, as it did in 59.1% of 66 half-faces in a Doppler study (Shen 2023, PMID 37327736). What has not been shown is the outcome. A 2026 practical review recommends routine Doppler mapping in the forehead, glabella, nose, and pyriform fossa, but it is an expert-opinion paper (level of evidence V), and we found no study comparing complication rates with and without ultrasound (Gonzalez 2026, PMID 41942642). Ultrasound shows what is there; it does not guarantee that an occlusion cannot happen.

Understand Your Risk, Make Informed Choices

Facial anatomical complexity reminds us that filler injection is not a "simple lunchtime procedure." Every needle operates in a three-dimensional space filled with vessels and nerves.

Questions to ask before treatment:

• Ask whether your injector uses ultrasound to check vessels and existing filler
• Know which vessels run under your injection area
• Confirm emergency protocols — does your injector have vascular occlusion emergency plans?
• Know when to seek help — immediate medical attention for blanching, severe pain, or vision changes

Filler migration and complications are closely related to anatomical structures. Learn about how fillers migrate and the complete filler repair evaluation process.

If you are facing filler-related concerns or suspect a vascular complication, FILLER REVISION provides ultrasound-guided assessment that maps your unique anatomy alongside existing filler deposits — because safe revision means seeing exactly what is there before taking any action.

Book a consultation →

Key Insight: Injection safety cannot rest on memorizing "average positions" from anatomy textbooks alone; it also means using ultrasound to see in real time where "this person's" vessels actually are. Personalized assessment begins with personalized visualization.

Frequently Asked Questions

Which areas of the face are the highest-risk injection zones, and why?

Published cases of blindness after filler cluster in the nose, forehead and glabella (between the eyebrows): 40%, 25% and 12% of the 226 injection sites in the 2025 American Academy of Ophthalmology report, with cases from the temple (9%) and nasolabial fold (4%) as well. Arteries in these areas connect with the ophthalmic artery, so filler that accidentally enters them can travel back to the eye and cause irreversible vision loss. The nose has an added difficulty: thin skin with little tissue beneath it, so filler can compress vessels, and vessel paths vary a lot between people. These percentages are counts of published cases, not the risk per injection.

What warning signs after a filler injection mean I should seek help immediately?

Seek immediate medical attention if you notice skin blanching (whitening), severe pain, or any vision changes after injection. These can signal vascular occlusion, which is a medical emergency: from the moment blanching, a color change, or any eye symptom appears (it is not always painful), there is no safe time to wait, and the earlier it is treated, the better. Acting quickly matters because the blockage can become irreversible. No pain does not mean you are fine: in a review of 365 cases of filler-related vision loss, pain was recorded in only 31.2% (Doyon 2024, PMID 38630871). If you have eye symptoms such as blurred vision, loss of vision, double vision, or a drooping eyelid, go straight to the emergency department or an ophthalmologist and contact the injecting clinic on the way; do not wait for a call back.

If textbooks describe a 'standard' facial anatomy, why do complications still happen with experienced injectors?

Facial vascular anatomy varies significantly between individuals, and the 'standard anatomy' in textbooks represents only statistical averages — your blood vessels may course in entirely different positions. Because the needle navigates blindly beneath the skin, even experienced injectors can encounter unexpected complications. This is why the article emphasizes assessing where your vessels actually are rather than relying on average positions.

What can ultrasound show that blind injection cannot?

High-resolution ultrasound allows the doctor to 'see' beneath the skin in real time, mapping your personal vascular anatomy before injection or revision and identifying variant arteries and prior filler residues that are hard to detect by touch alone. During the procedure it confirms needle position and helps avoid identified vessels, and afterward it checks the final filler distribution. The article frames this as replacing guesswork with imaging — seeing exactly what is there before taking any action. We found no study that measured whether this lowers the complication rate; ultrasound shows the vessels, but it does not guarantee that an occlusion cannot happen.

Is correcting or removing old filler safer than the original injection?

Not automatically — revision surgery in previously injected tissue carries the same anatomical risks as the original injection. Working in tissue already altered by prior injections, inflammation, or scarring is demanding because the vascular and nerve structures are still present, and in some cases their positions may have shifted due to the filler itself. This is why each revision at FILLER REVISION begins with ultrasound mapping of both the filler deposits and the surrounding vascular anatomy.

Where is the angular artery, and how deep is it?

The angular artery is the end portion of the facial artery near the inner corner of the eye, running up beside the nostril. Studies measured the facial artery at an average depth of about 4.7 mm between the nostril and the inner eye corner and about 2.4 mm at the inner eye corner, getting shallower as it rises (Trzeciak 2025, PMID 40164893). Not everyone's facial artery ends as an angular artery, though: in one Doppler study this was the case in 59.1% (Shen 2023, PMID 37327736).